Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BioDuro announced it has established a joint venture with Cenra API Solutions to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.
read more
Wednesday, April 29, 2026
BioDuro announced a strategic partnership with CTI Biotechnology to leverage the complementary strengths of both companies across critical stages of preclinical R&D to establish an integrated platform spanning from drug discovery to investigational ...
read more
Monday, December 09, 2019
BioDuro has announced the appointment of Kent Payne, Ph.D., as President of its CMC Global Solutions business unit.
read more
BioDuro announced the acquisition of Molecular Response and its translational oncology research platform, including its biobank of more than 100,000 viable tumor specimens.
read more
BioDuro, LLC, a global contract research organization (CRO) focused on fully outsourced turnkey discovery and development services in Oncology, Inflammatory Disease, Metabolism and CNS for pharmaceutical partners, has announced the formal launch of ...
read more
Tuesday, November 18, 2025
BioDuro announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company’s commitment to strengthening its peptide technology platform to meet ...
read more
BioDuro has broadly launched new antibody- and cell-based therapy discovery services.
read more
Tuesday, October 09, 2018
BioDuro has established a new drug discovery center for chemistry and biology in San Diego, CA.
read more
Thursday, November 12, 2015
BioDuro, a global CRO focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, announced the merger of its US operations with Formex, LLC, a provider of pharmaceutical API ...
read more
BioDuro, A PPD® Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific. The new lab...
read more
Tuesday, December 03, 2024
BioDuro-Sundia, a contract research, development, and manufacturing organization, announced the appointment of Alan Findlater as Chief Commercial Officer.
read more
Thursday, October 03, 2024
BioDuro-Sundia, a global contract research, development, and manufacturing organization (CRDMO), announced the launch of a new Compound Management Center at its Waigaoqiao site in the Shanghai Free-Trade Zone, China. This new center enables the ...
read more
Thursday, January 16, 2025
Biofidelity, and CellCarta announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.
read more
Thursday, January 09, 2025
Biofidelity and CellCarta announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials. Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analyzing both...
read more
Biofrontera has entered into an agreement to acquire all shares in Cutanea Life Sciences through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller.
read more